|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of products sold | |||||
| Gross profit | |||||
| Selling expense | |||||
| Selling and general expense | |||||
| Research and development expense | |||||
| General expense | |||||
| Intangible asset amortization expense | |||||
| Total nonmanufacturing expenses | |||||
| Goodwill impairment expense | |||||
| Restructuring and other impairment expense | |||||
| Operating profit (loss) | |||||
| Interest expense | |||||
| Loss on debt extinguishment | |||||
| Other expense, net | |||||
| Loss from continuing operations before income taxes | |||||
| Income tax expense (benefit) | |||||
| Net loss from continuing operations | |||||
| Income from discontinued operations, net of tax | |||||
| Net loss | |||||
| Dividends to participating securities | |||||
| Undistributed earnings available to common stockholders, basic | |||||
| Undistributed and distributed earnings (loss) available to common stockholders, basic | |||||
| Net income (loss) per share - basic: | |||||
| Loss per share from continuing operations (in dollars per share) | |||||
| Income per share from discontinued operations (in dollars per share) | |||||
| Basic (in dollars per share) | |||||
| Net income (loss) per share – diluted: | |||||
| Loss per share from continuing operations (in dollars per share) | |||||
| Income per share from discontinued operations (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...